Table 1.
Baseline characteristics
| VA (n = 235) | Community care (n = 235) | P | |
| Age, yr, mean ± SD | 64.6 ± 6.3 | 64.6 ± 6.3 | 1.00 |
| Male, n (%) | 225 (95.7) | 225 (95.7) | 0.83 |
| Screening, n (%) | 53 (22.6) | 53 (22.6) | 1.00 |
| Surveillance n, (%) | 119 (50.6) | 97 (41.3) | 0.04 |
| FIT, n (%) | 63 (26.8) | 86 (36.6) | 0.02 |
| Performed by nongastroenterologist, n (%) | 21 (8.9) | 24 (10.2) | 0.64 |
| DM, n (%) | 81 (34.5) | 102 (43.4) | 0.047 |
| Obesity, n (%) | 131 (55.7) | 110 (46.8) | 0.05 |
| Smoking, n (%) | 125 (53.2) | 166 (70.6) | <0.0001 |
| FHX of CRC, n (%) | 31 (13.2) | 24 (10.2) | 0.32 |
| Adequate bowel preparation, n (%) | 221/235 (94) | 96/142 (67.7) | <0.0001 |
| Quality reported, n (%) | 235 (100) | 142 (60.4) | <0.0001 |
| Cecal intubation rate, n (%) | 224 (95.3) | 213 (90.6) | 0.047 |
| Pathology reported, n (%) | 196 (84.9) | 116 (49.4) | <0.0001 |
| Surveillance documented, n (%) | 225 (95.7) | 163 (69.4) | <0.0001 |
| Surveillance appropriate, n (%) | 210/225 (93.3) | 122/163 (74.9) | <0.0001 |
| Time to procedure, median (IQR) | 49.5 (36–71) | 83.0 (57–109) | <0.0001 |
DM, diabetes mellitus; FHX of CRC, family history of colorectal cancer (first or second degree); FIT, fecal immunochemical test; IQR, interquartile range; VA, Veterans' Affairs.